Detalles de la búsqueda
1.
Improved patient- and caregiver-reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitis.
J Eur Acad Dermatol Venereol
; 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357778
2.
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment.
J Allergy Clin Immunol
; 152(5): 1179-1195, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315812
3.
The IL-4Rα Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice.
J Allergy Clin Immunol
; 151(5): 1296-1306.e7, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36690254
4.
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.
J Am Acad Dermatol
; 88(4): 816-823, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36473633
5.
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial.
J Eur Acad Dermatol Venereol
; 37(12): 2558-2568, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528500
6.
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.
J Eur Acad Dermatol Venereol
; 37(10): 2056-2066, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335885
7.
Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors.
J Allergy Clin Immunol
; 149(1): 145-155, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34111454
8.
JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes.
Int J Mol Sci
; 24(11)2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37298195
9.
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
Pediatr Dermatol
; 39(2): 187-196, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083774
10.
Multiethnic genome-wide and HLA association study of total serum IgE level.
J Allergy Clin Immunol
; 148(6): 1589-1595, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34536413
11.
Skin barrier defects in atopic dermatitis: From old idea to new opportunity.
Allergol Int
; 71(1): 3-13, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34916117
12.
Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum.
Allergy
; 76(8): 2510-2523, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33548076
13.
On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy.
J Allergy Clin Immunol
; 145(4): 1061-1071, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32057766
14.
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial.
J Allergy Clin Immunol
; 145(3): 877-884, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31786154
15.
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.
J Am Acad Dermatol
; 83(5): 1282-1293, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32574587
16.
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study.
J Am Acad Dermatol
; 82(2): 377-388, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31374300
17.
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
J Am Acad Dermatol
; 83(3): 839-846, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32344071
18.
Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions".
J Allergy Clin Immunol
; 143(3): 894-913, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30639346
19.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
N Engl J Med
; 375(24): 2335-2348, 2016 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27690741
20.
IgE Sensitization Drives the Atopic March.
Am J Respir Crit Care Med
; 207(5): 632-633, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36480963